Translational Cardiology
- Paperback
618 pages
- Release Date
20 January 2025
Summary
Translational Cardiology: Handbook for Designing and Conducting Translational Research
This handbook provides a comprehensive guide to the principles and practices of translational research in cardiology. It covers the entire spectrum of translational cardiology, from basic science discoveries to clinical applications and patient outcomes.
Key features include:
- In-depth exploration of the translational research spectrum: Delve …
Book Details
| ISBN-13: | 9780323917902 |
|---|---|
| ISBN-10: | 0323917909 |
| Author: | Jeffrey A. Bakal, Michael Gibson, Adam E.M. Eltorai |
| Publisher: | Elsevier Science & Technology |
| Imprint: | Academic Press Inc |
| Format: | Paperback |
| Number of Pages: | 618 |
| Release Date: | 20 January 2025 |
| Weight: | 1.64kg |
| Dimensions: | 216mm x 276mm |
| Series: | Handbook for Designing and Conducting Clinical and Translational Research |
You Can Find This Book In
Jeffrey A. Bakal
Dr. Bakal is the Program Director for Provincial Research Data Services at Alberta Health Services, which operates the Alberta Strategy for Patient Oriented Research (SPOR) data platform. He also leads the Health Service Statistical and Analytics Methods teams. Over 10 years, he has worked with health services data, including randomized clinical trials. He completed his PhD jointly through the Department of Mathematics and Statistics and the School of Physical Health and Education at Queen’s University. His work includes methodological contributions and analyses supporting international studies spanning business strategy, ophthalmology, cardiology, and geriatric medicine, as well as analyses of kinematic data, through peer-reviewed publications and conference presentations. Current interests include developing statistical methodology for time-to-event data and building classification tools to support patient decision-making processes.
C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher, and educator who pioneered our understanding of the “open artery hypothesis” as well as our understanding of the importance of restoring flow downstream in the capillary bed in the “open microvasculature hypothesis” in heart attack. Gibson has been a leading investigator in trials of thrombolytic agents, glycoprotein 2b3a inhibitor agents, thienopyridines, factor Xa inhibitors, lipid lowering agents, and new devices. Gibson was named one of the world’s most widely published and cited scientists of the past decade in 2014 by Thomson Reuters. For years, Gibson has been chosen as one of Boston’s Top Doctors & U.S. News & World Report also lists Gibson as one of America’s top doctors. He has held numerous leadership positions in medicine, including positions as a Coronary Care Unit Director, a Cardiac Catheterization Laboratory Director, a Chief of Cardiology, and as a Vice Chairman of Medicine.
Dr. Adam E. M. Eltorai, MD, PhD completed his graduate studies in Biomedical Engineering and Biotechnology along with his medical degree from Brown University. His work has spanned the translational spectrum with a focus on medical technology innovation and development. Dr. Eltorai has published numerous articles and books.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.